In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 8.2 | 3.5 | 7.1 | 7.9 | 6.5 | 3.7 | 3.0 | 4.6 | 3.8 | 3.9 | 3.0 | 3.7 | |
| Other Income | -0.8 | 0.9 | 1.4 | 2.0 | 1.5 | 0.7 | 0.6 | 2.0 | 1.0 | 1.6 | 0.5 | 2.3 | |
| Total Income | 7.5 | 4.4 | 8.5 | 9.9 | 8.1 | 4.4 | 3.6 | 6.6 | 4.8 | 5.5 | 3.6 | 6.0 | |
| Expenses | |||||||||||||
| + Changes in Inventories | 0.9 | 0.0 | 0.7 | 0.5 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Employee Benefit Expense | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| + Finance Costs | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Depreciation & Amortisation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Other Expenses | 0.6 | 0.5 | 0.7 | 0.6 | 0.6 | 1.3 | 0.5 | 0.6 | 0.5 | 0.5 | 0.6 | 0.7 | |
| Total Expenses | 1.7 | 0.8 | 1.7 | 1.3 | 1.1 | 1.6 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | |
| EBITDA | 6.5 | 2.7 | 5.4 | 6.6 | 5.4 | 2.1 | 2.3 | 3.8 | 3.1 | 3.2 | 2.2 | 2.8 | |
| EBIT | 6.5 | 2.7 | 5.4 | 6.6 | 5.4 | 2.1 | 2.3 | 3.8 | 3.0 | 3.1 | 2.2 | 2.8 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 5.8 | 3.6 | 6.8 | 8.5 | 7.0 | 2.8 | 2.8 | 5.8 | 4.0 | 4.7 | 2.7 | 5.1 | |
| Pretax Income | 5.8 | 3.6 | 6.8 | 8.5 | 7.0 | 2.8 | 2.8 | 5.8 | 4.0 | 4.7 | 2.7 | 5.1 | |
| + Current Tax | 1.2 | 0.5 | 0.0 | 1.4 | 1.3 | 0.5 | 0.5 | 1.0 | 0.5 | 1.0 | 0.0 | 0.7 | |
| + Deferred Tax | -0.0 | -0.0 | -0.1 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | 0.0 | -0.0 | |
| Tax Expense | 1.2 | 0.5 | -0.1 | 1.4 | 1.3 | 0.5 | 0.5 | 1.0 | 0.5 | 0.9 | 0.0 | 0.7 | |
| Net Income | 4.6 | 3.1 | 6.9 | 7.1 | 5.7 | 2.3 | 2.3 | 4.8 | 3.5 | 3.8 | 2.7 | 4.4 | |
| + Net Income — Continuing Ops | 4.6 | 3.1 | 6.9 | 7.1 | 5.7 | 2.3 | 2.3 | 4.8 | 3.5 | 3.8 | 2.7 | 4.4 | |
| + Other Comprehensive Income | 2.7 | 14.1 | -6.9 | 26.3 | 12.5 | -10.8 | -6.6 | -5.5 | -9.3 | -4.4 | -7.7 | 22.5 | |
| Total Comprehensive Income | 7.2 | 17.2 | -0.1 | 33.5 | 18.1 | -8.5 | -4.2 | -0.7 | -5.7 | -0.6 | -5.0 | 26.9 | |
| Per Share | |||||||||||||
| Basic EPS | 1.13 | 0.78 | 1.71 | 1.77 | 1.40 | 0.58 | 0.58 | 1.19 | 0.88 | 0.93 | 0.67 | 1.10 | |
| Diluted EPS | 1.13 | 0.78 | 1.71 | 1.77 | 1.40 | 0.58 | 0.58 | 1.19 | 0.88 | 0.93 | 0.67 | 1.10 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -6.6 | -5.5 | -9.3 | -4.4 | -7.7 | 22.5 | |
| + Items NOT to be Reclassified to P&L | 2.7 | 14.1 | -6.9 | 26.3 | 12.5 | -10.8 | -6.6 | -5.5 | -9.3 | -4.4 | -7.7 | 22.5 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 1.13 | 0.78 | 1.71 | 1.77 | 1.40 | 0.58 | 0.58 | 1.19 | 0.88 | 0.93 | 0.67 | 1.10 | |
| Diluted EPS — Continuing Operations | 1.13 | 0.78 | 1.71 | 1.77 | 1.40 | 0.58 | 0.58 | 1.19 | 0.88 | 0.93 | 0.67 | 1.10 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 9.3 | — | 0.6 | — | 3.4 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 7.4 | 3.5 | 6.4 | 7.4 | 6.3 | 3.7 | 3.0 | 4.6 | 3.8 | 3.9 | 3.0 | 3.7 | |
| Gross Margin % | 89.43 | 100.00 | 89.98 | 93.77 | 96.23 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 5.8 | 3.6 | 6.8 | 8.5 | 7.0 | 2.8 | 2.8 | 5.8 | 4.0 | 4.7 | 2.7 | 5.1 | |
| Net Income Adj (tax-effected) | 4.6 | 3.1 | 6.9 | 7.1 | 5.7 | 2.3 | 2.3 | 4.8 | 3.5 | 3.8 | 2.7 | 4.4 | |
| EPS Adj | 1.13 | 0.78 | 1.71 | 1.77 | 1.40 | 0.58 | 0.58 | 1.19 | 0.88 | 0.93 | 0.67 | 1.10 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |
| Paid Up Equity Capital | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | 8.1 | |